Budget 2026: Pharma, med-tech companies seek PLI extension to cover AP
Pharma and medtech experts seek PLI extension to APIs, stronger innovation support, and lower duties on advanced cancer radiation equipment.
Read More
Budget 2026: Multinationals calls for easing customs levies on critica
MNCs urge duty cuts on imported critical-care devices, warning high taxes can push costs up to 30% and hurt affordability and patient access for hospitals
Read More
Budget 2026-27: Health sector seeks tax relief, rationalised rates
Healthcare, medtech, and pharma firms seek Budget 2026–27 tax relief, more R&D funding, and support for local manufacturing and preventive care.
Read More
Dignified End-Of-Life Care Is A Core Public Health Need
MTaI’s Nadeem Anam highlights India’s urgent need for tech-enabled, home-based palliative care to ensure dignity for a rapidly ageing population.
Read More
When a software is your medical device
Amid growing digitisation, medical device makers want clear guidelines that ensure patient safety without stifling business growth.
Read More
CDSCO brings updated guidance on med device software
The 76-page draft outlines updated guidance on different types of software, applicable standards, quality management systems, and licensing authorities. However, in a statement, MTaI voiced that the final document should provide ‘greater clarity on evaluation protocols for AI/ML-based medical devices.
Read More
MTaI Applauds CDSCO’s Draft Guidance On Medical Device Software
The Medical Technology Association of India (MTaI) welcomes CDSCO’s draft framework for medical device software, calling it a key step toward digital health innovation.
Read More
GST Reforms To Make Healthcare, Insurance More Affordable: Experts
GST Council slashes tax on cancer drugs, insurance, devices, and nutrition, boosting affordability, easing patient costs, and promoting preventive care; experts call it a milestone in healthcare reform.
Read More
Drug, device makers should follow market entry pricing for marketing samples: Govt
According to a circular by the Department of Pharmaceuticals, under the UCPMP disclosure, free evaluation samples distributed to healthcare professionals should be valued on the same price charged to the stockist or immediate customer on a per unit basis.
Read More